In addition, Mdivi-1 allowed the reversal of the effect of CML-BSA on the expression of MFN2, p-STAT3, and p-JAK2 (Figure 3(a)). The gene discussed is JAK2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.